Post-Translational Regulation of ARF: Perspective in Cancer

Bibliographic Details
Title: Post-Translational Regulation of ARF: Perspective in Cancer
Authors: Jinho Seo, Daehyeon Seong, Seung Ri Lee, Doo-Byoung Oh, Jaewhan Song
Source: Biomolecules, Vol 10, Iss 8, p 1143 (2020)
Publisher Information: MDPI AG, 2020.
Publication Year: 2020
Collection: LCC:Microbiology
Subject Terms: ARF, post-translational modification, transcriptional regulation, tumor suppressor, cancer, p14, Microbiology, QR1-502
More Details: Tumorigenesis can be induced by various stresses that cause aberrant DNA mutations and unhindered cell proliferation. Under such conditions, normal cells autonomously induce defense mechanisms, thereby stimulating tumor suppressor activation. ARF, encoded by the CDKN2a locus, is one of the most frequently mutated or deleted tumor suppressors in human cancer. The safeguard roles of ARF in tumorigenesis are mainly mediated via the MDM2-p53 axis, which plays a prominent role in tumor suppression. Under normal conditions, low p53 expression is stringently regulated by its target gene, MDM2 E3 ligase, which induces p53 degradation in a ubiquitin-proteasome-dependent manner. Oncogenic signals induced by MYC, RAS, and E2Fs trap MDM2 in the inhibited state by inducing ARF expression as a safeguard measure, thereby activating the tumor-suppressive function of p53. In addition to the MDM2-p53 axis, ARF can also interact with diverse proteins and regulate various cellular functions, such as cellular senescence, apoptosis, and anoikis, in a p53-independent manner. As the evidence indicating ARF as a key tumor suppressor has been accumulated, there is growing evidence that ARF is sophisticatedly fine-tuned by the diverse factors through transcriptional and post-translational regulatory mechanisms. In this review, we mainly focused on how cancer cells employ transcriptional and post-translational regulatory mechanisms to manipulate ARF activities to circumvent the tumor-suppressive function of ARF. We further discussed the clinical implications of ARF in human cancer.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 10081143
2218-273X
Relation: https://www.mdpi.com/2218-273X/10/8/1143; https://doaj.org/toc/2218-273X
DOI: 10.3390/biom10081143
Access URL: https://doaj.org/article/9d7eb6b8731645c0a822b6bea798b419
Accession Number: edsdoj.9d7eb6b8731645c0a822b6bea798b419
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:10081143
2218273X
DOI:10.3390/biom10081143
Published in:Biomolecules
Language:English